Prof. Dr. Michael Laxy
|Professorship of Public Health & Prävention |
Technical University of Munich
Michael Laxy leads the Professorship of Public Health and Prevention at the Faculty of Sport and Health Sciences. Before his appointment at TUM, he led the working group on ‘Economics of Diabetes’ at the Institute of Health Economics and Health Care Management at Helmholtz Zentrum München.
Prof. Laxy studied public health (MPH), epidemiology (MSc), economics and sports science (BSc) at the Ludwig-Maximilians-University Munich (LMU), the Fernuniversität Hagen and at TUM. During his PhD at LMU focusing on economic aspects of diabetes care, he held research positions at the Helmholtz Zentrum München and the University of Cambridge. 2017/2018 he was a Harkness Fellow for Health Care Policy and Practice at the US Centers for Disease Control and Prevention. Since 2019, he serves as an adjunct professor at Emory University – Rollins School of Public Health. In December 2020, Prof. Laxy was appointed by TUM as professor for ‘Public Health and Prevention’.
Prof. Laxy studies disease prevention in the context of public health and health care systems. His research concentrates on the analysis of determinates and consequences of chronic diseases as well as on the evaluation of prevention measures and health policies concerning their effectiveness, efficiency and distributional effects.
Emmert-Fees, K., Karl, F., von Philipsborn P., Rehfuess, E., Laxy M.: Simulation Modelling for the Economic Evaluation of Population-Based Dietary Policies: A Systematic Scoping Review. Advances in Nutrition 2021
Pedron, P., Kurz, CF., Schwettmann, L., Laxy, M.: The Effect of BMI and Type 2 Diabetes on Socioeconomic Status: A Two-Sample Multivariable Mendelian Randomization Study. Diabetes Care 2021
Laxy M, Becker J, Kähm K, Holle R, Peters A, Thorand B, et al. Utility Decrements Associated With Diabetes and Related Complications: Estimates From a Population-Based Study in Germany. Value in Health 2021
Shao H, Laxy M, Gregg EW, Albright A, Zhang P. Cost-Effectiveness of the New 2018 American College of Physicians Glycemic Control Guidance Statements Among US Adults With Type 2 Diabetes. Value in Health. 2021
Laxy, M., Zhang, P., Ng, B., Shao, H., Ali, MK., Albright, A., Gregg E.: Implementing Lifestyle Change Interventions to Prevent Type 2 Diabetes in US Medicaid Programs: Cost Effectiveness, and Cost, Health, and Health Equity Impact. Applied Health Economics and Health Policy 2020
Kurz, C., Laxy, M.: Association of Obesity with Health Care Costs: A Mendelian Randomization study. Medical Decision Making 2020
Pedron, S., Emmert-Fees, K., Laxy, M., Schwettmann L. The impact of diabetes on labour market participation: a systematic review of results and methods. BMC Public Health. 2019
Laxy, M., Schöning, V.M., Kurz, C., Holle, R., Peters, A., Meisinger, C., et al. Performance of the UKPDS outcomes model 2 for predicting death and cardiovascular events in patients with type 2 diabetes mellitus from a German population-based cohort. PharmacoEconomics. 2019
Karl, F.M., Holle, R., Schwettmann, L., Peters, A., Laxy, M. Status quo bias and health behavior: findings from a cross-sectional study. European Journal of Public Health 2019
Laxy, M., Wilson, E., Boothby, C., Griffin, S.: Incremental costs and cost-effectiveness of intensive treatment in patients with screen-detected type 2 diabetes in the ADDITION-UK trial: An update with empirical trial-based cost data. Value in Health 2017